智通财经APP讯,山东新华制药股份(00719)公布,近日,公司收到国家药品监督管理局核准签发的二十碳五烯酸乙酯《化学原料药上市申请批准通知书》。
新华制药于2025年5月获得二十碳五烯酸乙酯化学原料药上市申请批准通知书,上述产品的获批将进一步丰富公司产品线,提升公司综合竞争力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.